Open AccessSPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax
Author(s) -
Lu Liu,
Jing Liu,
Xiaojun Liu,
Meng-Han Liu,
Xuefeng Feng,
Lin Yang,
Juan Luo
Publication year - 2022
Publication title -
neoplasma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2022_220415n416
Subject(s) - myeloid leukemia , mapk/erk pathway , cancer research , venetoclax , gene knockdown , carcinogenesis , signal transduction , leukemia , myeloid , tyrosine kinase , biology , medicine , apoptosis , immunology , microbiology and biotechnology , cancer , genetics , chronic lymphocytic leukemia